Skip to main content
Asad Bashey, MD, Hematology, Atlanta, GA

AsadBasheyMD

Hematology Atlanta, GA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Director of Clinical Research for The Blood and Marrow Transplant Program at Northside Hospital.

Dr. Bashey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bashey's full profile

Already have an account?

  • Office

    5670 Peachtree Dunwoody Rd Ne
    Suite 1000
    Atlanta, GA 30342
    Phone+1 404-255-1930
    Fax+1 404-459-8510

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
  • Univ Dundee- Fac Med
    Univ Dundee- Fac MedClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1994 - 2026
  • GA State Medical License
    GA State Medical License 2005 - 2025
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Atlanta Magazine: Top Doctors Castle Connolly, 2013-2014, 2014-2022

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The European Society for Blood and Marrow Transplantation (EBMT) Consensus Recommendations for Donor Selection in Haploidentical Hematopoietic Cell Transplantation  
    Leo Luznik, Karen Ballen, Asad Bashey, Hillard M Lazarus, Bipin N Savani, Rizwan Romee, Ephraim J Fuchs, Nature

Abstracts/Posters

  • Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...
    Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Graft Versus Host Disease (GVHD) after HLA-Mismatched Haploidentical Transplantation with Post-Transplant Cyclophosphamide Compared to Matched Unrelated Donor: Inciden...
    Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
    Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Improved Survival in Patients Who Undergo Relapse of Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Improved Survival of Patients Diagnosed with Severe (Grade 3-4) Acute GVHD or Severe NIH Grade Chronic GVHD in the Current Era Compared to Historic Controls 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • The Choice of Induction Regimen Affects Post Remission Survival of Acute Myelogenous Leukemia (AML) Patients with Intermediate or Poor Risk Disease 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Late-Breaking Abstracts Session
    Late-Breaking Abstracts SessionDecember 6th, 2016

Grant Support

  • CTLA-4 Blockade In Allo Stem Cell TransplantationNational Cancer Institute2002–2004